16-2062962-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000548.5(TSC2):​c.1362-10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000336 in 1,549,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

TSC2
NM_000548.5 intron

Scores

2
Splicing: ADA: 0.00001193
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.133

Publications

1 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-2062962-C-T is Benign according to our data. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2062962-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 389376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAdExome4 allele frequency = 0.0000229 (32/1397076) while in subpopulation AFR AF = 0.00057 (18/31560). AF 95% confidence interval is 0.000368. There are 0 homozygotes in GnomAdExome4. There are 17 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 20 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC2NM_000548.5 linkc.1362-10C>T intron_variant Intron 13 of 41 ENST00000219476.9 NP_000539.2 P49815-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkc.1362-10C>T intron_variant Intron 13 of 41 5 NM_000548.5 ENSP00000219476.3 P49815-1

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152236
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000259
AC:
4
AN:
154196
AF XY:
0.0000246
show subpopulations
Gnomad AFR exome
AF:
0.000466
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000229
AC:
32
AN:
1397076
Hom.:
0
Cov.:
31
AF XY:
0.0000247
AC XY:
17
AN XY:
689098
show subpopulations
African (AFR)
AF:
0.000570
AC:
18
AN:
31560
American (AMR)
AF:
0.0000280
AC:
1
AN:
35694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25154
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35724
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79180
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48102
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5082
European-Non Finnish (NFE)
AF:
0.00000464
AC:
5
AN:
1078698
Other (OTH)
AF:
0.000104
AC:
6
AN:
57882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152236
Hom.:
0
Cov.:
33
AF XY:
0.000175
AC XY:
13
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.000386
AC:
16
AN:
41464
American (AMR)
AF:
0.000131
AC:
2
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000193

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tuberous sclerosis 2 Benign:3
Sep 05, 2024
Myriad Genetics, Inc.
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tuberous sclerosis syndrome Benign:1
Nov 08, 2022
Color Diagnostics, LLC DBA Color Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Sep 10, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Feb 23, 2021
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.8
DANN
Benign
0.48
PhyloP100
-0.13
PromoterAI
-0.022
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000012
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45446697; hg19: chr16-2112963; API